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Abstract Molecular mimicry has been shown between two se- 
quences of Kiebsieilapneumoniae puID secretion protein (DRDE) 
with HLA-B27 (DRED) and pulA (pullulanase) enzyme (Gly-X- 
Pro) with types I, lII and IV collagen respectively. IgG antibody 
levels in AS patients were elevated against 16mer synthetic pep- 
tides of HLA-B27 and pulD by enzyme linked immunosorbent 
assay (ELISA) compared to controls (P < 0.001). ELISA assays 
against K. pneumoniae grown in the absence and presence of 
pullulan demonstrated significant levels of IgA antibody in AS 
patients compared to controls (P < 0.001). Increased IgA and lgG 
antibody levels to pulA and types I and IV collagen were observed 
in AS patients compared to controls (P < 0.001). These observa- 
tions could be relevant in the sequence of molecular events in AS. 
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1. Introduction 
Ankylosing spondylitis (AS) is chronic inflammatory rheu- 
matic disorder particularly affecting the axial skeleton. A link 
between AS and the major histocompatibility antigen HLA- 
B27 has been well established [1]: over 95% of patients with AS 
are HLA-B27 positive [2,3]. There are seven subtypes of HLA- 
B27 ranging from B'2701 to B'2707. It has been suggested that 
B'2705 is the most common HLA-B27 subtype in Caucasian 
populations, whilst it is proposed that B'2703 is the most com- 
mon B27 antigen in black populations, where AS is rare. This 
observation has led to the suggestion that B'2703 is not associ- 
ated with AS [4]. Subtypes of HLA-B27, other than B'2705, 
containing different amino acid sequences are also involved in 
AS. In this paper the HLA-B27 subtype under examination is
B'2705. The cause of AS remains controversial, although an 
environmental gent in the form of the gram negative bacte- 
rium, Klehsiella pneumoniae, present in the gut, has been sug- 
gested as a possible aetiological agent [5] to which antibodies 
have been shown in several centres [6]. Any aetiological agent 
implicated in AS must provide an explanation for the link with 
HLA-B27. Schwimmbeck et al. [7] identified an amino acid 
homology, QTDRED found in residues 72-.-77 of B'2705 and 
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residues 188 193 of K. pneumoniae nitrogenase nzyme. The 
validity of this homology, as a cross reactive antigen, has how- 
ever, been criticised, in both biochemical and immunological 
terms. For nitrogenase production, an extremely low level of 
fixed nitrogen is required [8] and this condition is not achieved 
in the human gut. Additionally, extremely anaerobic onditions 
are required for nitrogenase production in Kh:bsiella [8], and 
whilst the human gut has a low level of oxygen, debate persists 
as to whether this degree of anaerobiosis i sufficient o allow 
nitrogenase production. Furthermore, HLA-B27 is a self pro- 
tein and therefore should not trigger an immune response. The 
part of K. pneumoniae nitrogenase thal contains the sequence 
QTDRED should been seen as self by the immune system, and 
theret\)re should not evoke an immune response. These criti- 
cisms have led to a re-evaluation of the relevance of K. pneumo- 
niae nitrogenase in AS and initiated the search for different 
sequence homologies between /(  imettmoniae proteins and 
B'2705. In this study a computer search has revealed a novel 
homology between B'2705 and another component of K. p/lt'll- 
moltiae in the form of the secretion protein {pulD) of the induc- 
ible, starch debranching enzyme pullulanase. Additionally, 
amino acid homology has been described between the extracel- 
lular starch induced enzyme pullulanase lpulA) and types l, III 
and IV collagen [9]. In the present study the effect of the induc- 
tion of the pullulanase system on serum antibody in AS patients 
has been studied using bacteria grown in the presence or ab- 
sence of the starch substrate pullulan. Furthermore, the levels 
of cross reactive antibodies between B'271)5 and pulD synthetic 
peptides, puta. and two types of colhtgcn tl and IV), have been 
measured in order to demonstrate their relevance in the devel- 
opment of the disease. 
2. Materials and methods 
2 1. Computer search 
The BLAST database searching program was used to search the 
PIR-Protein database (V.33.0) containing 42,215 sequences. The se- 
quence QTDRED from HLA-B27 and K. pneumoniae were compared 
with all the sequences in the database allowing fl~r mismalches. 
2.2. Patients 
Sera were collected from 97 active AS patients (New York criteria) 
(crythrocyte sedimentation rate (ESR) > 15 ram/h, all HLA-B27 posi- 
tive) attending the AS Research Clinic at the Middlesex Hospital. and 
25 active rheumatoid arthritis (RA) patients (ARA criteria) attending 
tile Rheumatology Department at the Lister Hospital, Stevenage, 
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Herts. The London Blood Transfusion Service provided 25 healthy 
control sera. All sera were stored at -20°C until required. 
2.3. Pcptide synthesis' and ELISA study 
The synthetic peptides were prepared by solid phase synthesis, purity 
assays were performed by high performance liquid chromatography. 
All peptides had a purity of at least 90%. Three 16mer peptides were 
constructed: the B'2705 sequence (residues 67 83) CKAKAQTDRED- 
LRTLL, the pulD secretion protein sequence (residues 590-605) 
RPTVIRDRDEYRQASS, and a control peptide sequence made from 
a scrambled sequence of the pulD peptide, RPTVRSDIDYRQAESR. 
Sera were tested against he three peptides by non competitive enzyme 
linked immunosorbent assay (ELISA). The assay was carried out as 
follows: polystyrene microtitre plates (Dynatech) were coated with the 
synthetic peptide (5.0,ug/well) overnight at 4°C. After absorption and 
washing with PBS-Tween, the plates were saturated with 2% casein- 
PBS-Tween, incubated for 1 h at 37°C, followed by washing with 
PBS-Tween. Serum samples (200pl at 1/50 dilution in PBS-Tween) were 
added to the plates, incubated for 90 min at room temperature, followed 
by washing with PBS-Tween and peroxidase conjugated rabbit anti- 
human class specific IgG, IgA or IgM (Dako. Ltd) diluted 1/500 in 
PBS-Tween added and plates incubated for 90 min at room tempera- 
ture. After washing and enzyme reaction with substrate 2,2'-azinobis(3- 
ethylbenz-thiazoline-6-sulphonic acid)(ABTS) (Sigma Chemical Co. 
Ltd.) at room temperature for 20 min, the reaction was stopped with 
sodium fluoride and the OD measured at wavelength of 630 nm. 
2.4. Organisms and growth conditions 
Proteus mirabilis was obtained from the Department of Microbiol- 
ogy, King's College whilst the Klebsiellapneumoniae used was a clinical 
isolate kindly provided by the Medical Microbiology Department, 
Princess Royal Hospital, Haywards Heath. The cultures were grown 
aerobically in 250 ml conical flasks on an orbital shaker for 16-18 h in 
minimal media supplemented with 0.005% yeast extract (Difco) [10]. If 
induction of the pullulanase nzyme system was required the starch 
substrate pullulan (0.3% w/v) (Sigma) was added to the minimal me- 
dium. The cells were harvested by centrifugation (MSE 18; 6 x 250 ml 
rotor) and washed in 0.15 M phosphate buffered saline (PBS). The 
suspension was then centrifuged as before. This procedure was repeated 
3 times. After washing, the cells were resuspended in 20 ml of PBS and 
a stock solution was prepared to give an OD reading of 0.25 on the 
Spectrophotometer (Corning Model 258). 
2.5. ELISA studies on the effect of antibody binding to bacteria grown 
in minimal media in the presence of pullulan 
Aliquots of 200 ,ul of the diluted suspension of bacteria grown on 
minimal media plus 0.005% yeast extract (Difco) were adsorbed onto 
96 well EL1SA plates (Dynatech) overnight at 4°C. The ELISA proce- 
dure was carried out as described previously, with the exception of the 
application of the HRP-conjugated second antibody. In this assay, 
when K. pneumoniae was used as the antigen the HRP-conjugated 
second antibody was of the lgA class, whilst when Proteus mirabilis was 
the antigen the HRP-conjugated antibody was of the IgG class. This 
experiment was repeated with a suspension of bacteria grown on min- 
imal media plus 0.005% yeast extract (Difco) supplemented with pullu- 
lan (Sigma) (0.3% w/v). 
2.6. ELISA studies on pullulanase (pulA) 
Aliquots (200,ul) of a solution of pullulanase (Sigma) (2/zg/well) were 
adsorbed onto 96-well ELISA plates (Dynatech) overnight at 4°C. The 
ELISA procedure was carried out as described previously, however 
only IgA and IgG classes of the HRP-conj ugated second antibody were 
used. 
2. 7. ELISA studies on collagen types I and IV 
Solutions of collagen type I or type IV (Sigma) (3 pg/ml) were ad- 
sorbed onto 96-well ELISA plates (Dynatech) overnight at 4°C in 200 
/tl volumes. The ELISA plate was washed and satured with 2% casein- 
PBS-Tween described previously, however incubation for 1 h was per- 
formed at room temperature. Additionally, only IgA and IgG classes 
of the HRP-conjugated second antibody were used in this assay. 
3. Results 
3.1. Amino acid sequence homology between B'2705 and 
Klebsiella pneumoniae 
The computer search revealed a number of sequence homol- 
ogies between B'2705 and various microorganisms including 
the nitrogenase protein of K. pneumoniae as had been reported 
previously by Schwimmbeck et al. [7]. The mismatch function 
revealed the presence of another sequence in K. pneumoniae 
that showed homology with the QTDRED region in B'2705. 
This sequence was a tetramer present in the pullulanase secre- 
tion protein pulD (residues 596-599) of a starch debranching 
enzyme present in K. pneumoniae (Table 1). The pulD sequence 
was the second amino acid homology to be identified between 
the hypervariable domain of B'2705 and the gram negative 
bacteria K. pneumoniae. 
3.2. Peptide EL ISA study 
ELISA assays performed on the B'2705 synthetic peptide 
showed significant antibody elevation in AS patients in IgG 
(P < 0.001) antibody class, when compared to control subjects 
but no significant elevation in IgA or IgM antibodies. Further- 
more, in the RA patients no significant elevation of IgA, IgM 
or IgG classes were detected when compared to controls (Fig. 
1A). 
Assays performed on the pulD peptide demonstrated signif- 
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Fig. 1. Antibody titres (mean + S.E.M.) for IgA, IgM and IgG in 25 controls (C), 25 rheumatoid arthritis (RA) patients and 97 ankylosing spondylitis 
(AS) patients when tested by ELISA against 16mer peptides of HLA-B27 (A), pulD (B) and control peptide (scrambled pulD) (C). OD = optical 
density; n.s. = not significant. 
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Fig. 2. Antibody titres (mean _+ S.E.M.) for lgA in 25 controls (C), 25 rheumatoid arthritis (RA) patients and 97 ankylosing spondylitis (ASI patients 
when tested by ELISA against aclinical isolate of Klebsiella pneumoniae (A) and of Proteu,~ mirabilis (B) grown in the absence and the presence of
pultulan. OD = optical density: n.s. = not significant. 
icant antibody elevations in AS patients, in all three antibody 
classes, IgA (P < 0.005), IgM (P < 0.050) and IgG (P < 0.001) 
when compared to controls. The RA patients howed no signif- 
icant antibody elevations in IgA, IgM or IgG classes with re- 
spect to control subjects (Fig. 1B). 
EL1SA studies on the control peptide demonstrated no sig- 
nificant elevations with IgA, IgM or IgG antibody classes in 
RA or AS patients when compared to control subjects (Fig. 
IC). 
3.3. Effect q/baeterial growth conditions with respect o 
antibody binding 
Determination f antibody levels in AS patients to K. pneu- 
moniae grown in minimal media with yeast extract showed 
elevation in |gA antibody titres (P < 0.00l) when compared to 
controls (Fig. 2A). This observation confirms previous reports 
of elevation of the IgA response to K. pneumoniae in AS pa- 
tients [6]. When the experiment is repeated with the addition of 
the starch component, pullulan (Sigma) to the medium (0.3% 
w/v) the level of IgA binding in AS patients was again elevated 
Table 1 
Comparison of amino acid sequence homologies between HLA-B27 
and proteins from Klebsiella pneumoniae 
Protein Residues Amino acid sequence 
HLA-B27 67 82 
Klebsiellu pneumoniae 
nitrogenase 184- 199 
Klebsiella pneumoniae 
pulD secretion protein 590 605 
CKAKAQTDREDLRTLL 
CNSRQTDREDELIGGC 
RPTVIRDRDEYRQASS 
Regions of homology between HLA-B27, K. pneumoniae nitrogenase 
enzyme and K. pneumoniae pulD secretion protein are underlined. 
(P < 0.001) when compared to control subjects (Fig. 2A). This 
increase in the level of antibody binding is likely to be due to 
the development of capsular polysaccharide oil the cell surface 
of the bacteria. 
The assay was repeated using another gram negative nteric 
organism, Proteus mirabilis, grown under exactly the same con- 
ditions as K. pneumoniae on minimal media in the absence and 
presence of pullulan. Measurement of the lgG response was 
performed by the use of an EL1SA assay. Significant and spe- 
cific antibody elevations were observed in the RA patients, 
confirming previous observations [1 I]. The antibody elevations 
were observed in the RA patients regardless of" the presence 
(P < 0.001) (Fig. 2B) or absence (P < 0.001) (Fig. 2B) of pullu- 
lan when compared to controls. Furthermore the levels of anti- 
body titres in the AS, RA or control group did not appear to 
be affected by the presence or absence of pullulan in the growth 
media of P. mirahilis. 
3.4. Determination o]the level q/serum antibodies to t/re 
pullulanase (pulA ) enzyme 
Titres of both IgA and IgG antibody classes were determined 
by ELISA to a pullulanase target. AS patients howed titres of 
lgA (P < 0.001) in comparison to control subjects. The level of 
the IgG response showed similar elevations (P < 0.001) when 
compared to controls. However, the RA patients howed no 
significant elevation in IgA or IgG response with respect o the 
control group (Fig. 3). 
3.5. ELISA studies on type 1 and O'pe IV eolla,~en 
IgA elevations to both type I (P<0.001) and type [V 
(P < 0.001) collagen was observed in AS patients in comparison 
to controls (Fig. 4A). lgG responses to collagen type I 
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Fig. 3. Titres of IgA and IgG antibody (mean _+ S.E.M.) in 25 controls 
(C), 25 rheumatoid arthritis (RA) patients and 97 ankylosing spondyli- 
tis (AS) patients when tested by ELISA against pullulanase nzyme 
(pulA). OD = optical density; n.s. = not significant. 
(P < 0.001) and type IV (P < 0.001) were elevated with respect 
to controls (Fig. 4B). The RA patients howed no significant 
IgA or lgG antibody elevations to type I or type IV collagen 
when compared to controls (Fig. 4A and B). 
4. Discussion 
Antibody elevations to Klebsiella pneumoniae in AS patients 
were first reported in 1983 [5] and those original observations 
have since been confirmed in various centres [6]. Furthermore, 
antibodies to other gram negative organisms uch as Escherie- 
hia coli, Proteus mirabilis, Pseudomonas eruginosa, Salmonella 
spp, Shigella spp, and Yersinia enterolitica have not been found 
to be elevated in AS patients [5]. Additionally, a strong associ- 
ation between HLA-B27 and AS has been known for over 20 
years [1]. These two observations were linked in 1987 [7] in the 
form of an amino acid homology between B'2705 and K. pneu- 
moniae nitrogenase. The data presented in this paper suggests 
a new sequence homology between B'2705 and another protein 
present in K. pneumoniae, the pulD secretion protein of the 
starch debranching pullulanase enzyme system (Table 1). 
Whilst the pulD sequence does not display the 100% homology 
shown with K. pneumoniae nitrogenase a similarity is nonethe- 
less present in the form of a tetramer, (residues 596 599) 
(DRDE) and B'2705 (DRED). The pulD sequence (residues 
596 599) only differs from the DRED sequence in B'2705 
(74 77) and K. pneumoniae nitrogenase (190-193) by two con- 
servative substitutions, one, a D (aspartic acid) for an E (glu- 
tamic acid) at position 598 and the second, of an E (glutamic 
acid) for a D (aspartic acid) at position 599. It is clear to see 
that this sequence (underlined) falls within the region of homol- 
ogy previously published by Schwimmbeck et al. [7] (Table l). 
Various other proteins from enteric bacteria have been 
shown to have sequence homology with HLA-B27 [12]. These 
include sequences from common gram negative organisms such 
as E. coli, Salmonella, Shigella, Pseudomonas nd Klebsiella. It 
has been suggested that the mechanism for the apparent au- 
toimmune condition in AS occurs from the breakdown in toler- 
ance of the host to its own HLA-B27 molecule and the en- 
dogenous peptides bound therein. Once the host is exposed to 
enteric peptides of similar sequence to that of HLA-B27 an 
immune response may be evoked. It is this immune response 
that may breach tolerance and so initiate a chronic inflamma- 
tory condition such as that seen in AS [12]. However, antibody 
levels against various organisms, (such as those shown to have 
similar sequences to HLA-B27) in AS patients revealed no 
specific elevation in immunoglobulin levels with respect to con- 
trols with the exception of K. pneumoniae [5]. 
The pulD is the terminal secretion protein of the pullulanase 
system and is known to have regions said to form strongly 
amphiphatic fl sheets which confer membrane spanning proper- 
ties common to outer membrane proteins [13]. This suggests 
that the protein should be on the surface of the organism and 
freely accessible to the surveillance of the immune system. The 
data obtained from the ELISA studies with synthetic peptides 
demonstrate hat the AS patients have antibodies to the 16 mer 
B'2705 and pulD peptides. The AS patients howed significant 
elevations in both IgA and IgG antibody classes to the B'2705 
peptide. This binding to a peptide of a self protein demonstrates 
the presence of autoantibodies in the sera of AS patients. It is, 
therefore, possible that these antibodies may bind HLA-B27 
positive cells in patients, fix complement and thereby initiate 
inflammation. The microbial source, evoking these antibodies 
could be in the form of the pulD protein ofK. pneumoniae. The 
ELISA data with the pulD synthetic peptide yielded similar 
data to that obtained with B'2705. The pulD peptide antibody 
elevations were seen in all three antibody classes whilst, with 
the control peptide (scrambled pulD peptide), no antibody ele- 
vations were observed in any patient group to any antibody 
class. The data derived from the B'2705 and pulD peptide 
binding suggests that there is some degree of molecular mimicry 
or cross reactivity between the two sequences, one self and one 
microbial. 
The presence of the pullulanase system in K. pneumoniae 
allows the organism to cleave ~( 1 6) bonds in ~( 1 M) and ~(1-6) 
branched starches uch as glycogen and amylopectin. The effect 
of this property is that the organism gains access to another 
carbon source, which can alter the type of antigens presented 
on the surface of the bacteria leading to the development of the 
polysaccharide capsule layer and so alters the level of patients 
serum antibody binding. This can be seen in Fig. 2A, where K. 
pneumoniae has been grown in a minimal medium with 0.005% 
yeast extract. When organisms grown in this media were ex- 
posed to sera from AS patients and healthy and disease (RA 
patients) controls an elevation in antibody titre is observed. 
However, if the organism is grown on the same media supple- 
mented with pullulan (0.3% w/v) as the carbon source the de- 
gree of antibody binding in AS patients is greatly increased. 
This increase also shows that the capsule is highly antigenic and 
is one of the predominant antigens recognised by AS patients, 
an observation also made by other workers [14]. In the control 
experiment, where P mirabilis is grown in the same conditions, 
with and without pullulan, antibody elevations are only seen in 
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Fig. 4. lgA (A) and IgG (B) antibody titres (mean _+ S.E.M.) in 25 
controls (CI. 25 rheumatoid arthritis (RA) patients and 97 ankylosing 
spondylitis (AS) patients when tested by ELISA against type 1 and type 
IV collagen. OD = optical density: n.s. = not significant. 
RA patients not AS or healthy controls. Importantly, there is 
no significant difference in the antibody binding capacity of P. 
mirabilis when grown in the presence or the absence of pullulan, 
regardless of whether the sera is from patients or healthy con- 
trols (Fig. 2B). 
IgA and lgG antibody titres were also found to be elevated 
against he extracellular enzyme pullulanase (pulA) in AS pa- 
tients when compared to controls. The pulA enzyme would 
appear to have a very important property in relation to arthritic 
disease. At the N-terminal end of the pulA protein in some 
strains of K. pneumoniae there are repeats of the tripeptide 
Gly-X-Pro, characteristic of collagens type I, type It1 and type 
IV [9]. lgA and IgG antibody elevations to both type I and type 
IV collagens have been demonstrated in AS patients compared 
to controls. It is interesting to note that type I collagen is 
present predominantly in tendons and bone [15]. The possibility 
of antibodies cross reacting between pulA and type I collagen 
may be important in the deposition of fibrous tissue in the axial 
skeleton and the development of inflammation at the entheses 
(enthesitis). 
Histological changes in thigh muscle biopsies of AS patients 
have previously been reported [16] and type Ill collagen is 
reported to be present in muscle tissuc [15] and type IV collagen 
is present in basement membranes, basal lamina, retina and 
cornea. AS patients often suffer from acute anterior uvcitis 
(AAU), which could be triggered by some of these a nti-collagen 
antibodies. The antibody binding to putA, type 1 and type IV 
collagen demonstrated here, as well as the suggested cross reac- 
tivity between pulA and collagen type 1[1 may explain some of 
the pathological features of AS. 
The potential role of B'2705 and the other subtypes of H LA- 
B27 in the initiation of an immune response, m tissue typed 
patients and tissue typed controls, with an intestinal infection 
with a gram negative bacteria such as K. lmetumntiae needs to 
be investigated further. However. studies performed on tissue 
typed AS patients against a homologous MHC background in 
tissue typed control subjects, have shown elevations in antibody 
to K. Imeunumiae when compared to the control patients [I 7]. 
The fact that both the disease and conlrol populations were 
tissue typed for HLA-B27 precluded the potentiality Rw the 
responses een in the test groups to be due to the humoral 
immune response against K. lmeUmoniac to be influenced b~ the 
MHC class. 
AS patients are usually treated by the administration fanti-  
inflammator.x drugs. However, other treatments such as special 
diets have been proposed. Patients treated with a low starch 
diet in an open study over a 9-month period demonstrated a 
decrease in acute phase reactants (ESR and C reactive protein 
levels) and serum lgA levels [18]. [t is possible that this low 
starch diet may affect the bowel flora by substrate depletion. 
This may decrease or even prevent he induction of substrate 
dependent enzymes and proteins such as those in the pullula- 
nase system thereby possibly modit~'ing the disease outcome. 
The inx, olvement of inducible nzymes and proteins in bacteria 
related to rheumatic disorders such as AS, may explain the 
observed patterns of exacerbations and remissions. 
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